Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0000919574-25-002456
Filing Date
2025-04-15
Accepted
2025-04-15 12:17:36
Documents
1
Effectiveness Date
2025-04-15
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7055
  Complete submission text file 0000919574-25-002456.txt   8250
Mailing Address 300 PARK AVENUE 5TH FLOOR, SUITE 519 NEW YORK NY 10022
Business Address 300 PARK AVENUE 5TH FLOOR, SUITE 519 NEW YORK NY 10022 212-480-8420
Zakara Biotechnology Fund LP (Filer) CIK: 0002058789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-543714 | Film No.: 25838339